190 results on '"Staser, Karl"'
Search Results
2. A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
3. A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
4. Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR
5. Immunotherapy for T-Cell ALL and T-Cell NHL
6. Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model
7. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review
8. Research Techniques Made Simple: CAR T-Cell Therapy
9. The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia
10. Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models
11. Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease
12. An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
13. Single Cell Assay, Hematopoietic Stem Cell
14. A Pak1-PP2A-ERM signaling axis mediates F-actin rearrangement and degranulation in mast cells
15. Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
16. Kinase suppressor of Ras (KSR1) modulates multiple kit-ligand−dependent mast cell functions
17. Combined Treatment of Baricitinib and Cyclosporin Prevents Solid Organ Graft Rejection in Mice
18. Mast cells and the neurofibroma microenvironment
19. Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
20. The Plexiform Neurofibroma Microenvironment
21. An “Off-the-Shelf” CD2 Universal CAR-T Therapy Combined with a Long-Acting IL-7 for T-Cell Malignancies
22. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation
23. Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR
24. Histopathologic and immunophenotypic features of cutaneous solid organ transplant‐associated graft‐vs‐host disease: Comparison with acute hematopoietic cell transplant‐associated graft‐vs‐host disease and cutaneous drug eruption
25. Multiple increased osteoclast functions in individuals with neurofibromatosis type 1
26. 364 - Combined Treatment of Baricitinib and Cyclosporin Prevents Solid Organ Graft Rejection in Mice
27. Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response
28. Modeling Sézary Syndrome for Immunophenotyping and Anti-Tumor Effect of Ucart and Long-Acting Interleukin-7 Combination Therapy
29. A Long-Acting Pharmacological Grade Interleukin-7 Molecule Logarithmically Accelerates CART Proliferation, Differentiation, and Tumor Killing
30. Modeling Sézary Syndrome for Immunophenotyping and Anti-Tumor Effect of Ucart and Long-Acting Interleukin-7 Combination Therapy
31. A Long-Acting Pharmacological Grade Interleukin-7 Molecule Logarithmically Accelerates Ucart Proliferation, Differentiation, and Tumor Killing
32. Baricitinib Prevents and Treats GvHD through Both Immune Modulation and Enhancement of Tissue Repair
33. A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas
34. Modeling Chronic Graft Versus Host Disease in Mice Using Allogeneic Bone Marrow and Splenocyte Transfer
35. OMIP‐042: 21‐color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood
36. An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies
37. Injection-Site Cutaneous Pseudolymphoma Induced by a GM-CSF–Producing Tumor Cell Vaccine
38. Nf1 haploinsufficiency alters myeloid lineage commitment and function, leading to deranged skeletal homeostasis
39. proteasome-resistant fragment of NIK mediates oncogenic NF- κ B signaling in schwannomas.
40. OMIP‐042: 21‐color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood.
41. Nf1Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis
42. Pak2 Regulates Hematopoietic Progenitor Cell Proliferation, Survival, and Differentiation
43. Pleomorphic soft tissue sarcoma metastatic to the skin of the scalp and groin
44. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation
45. The Beak Sign
46. Hyperactive Transforming Growth Factor-β1 Signaling Potentiates Skeletal Defects in a Neurofibromatosis Type 1 Mouse Model
47. Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
48. Haploinsufficiency of Nf1 in Myeloid Lineages Contributes to Neurofibromatosis Type 1 Associated Skeletal Deficits
49. Identification of molecular compartments and genetic circuitry in the developing mammalian kidney
50. Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal/Hematopoietic Interactions in Tumor Progression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.